Ion Exchange (india) Ltd. · NSE:IONEXCHANG

Ion Exchange (india) — H1 FY2021 Earnings Presentation

24 slides from Ion Exchange (india)'s earnings presentation, Nov 12, 2020

  1. Slide 1: Submission of Analyst / Investor Presentation to BSE

    8 ION EXCHANGE /2e,f;Jve)v~ ~ P~nd November 12, 2020 To, BSE Limited The Corporate Relationship Dept. P.J. Towers, Dalal Street, Mumbai - 400 001 BSE Company Code: 500214 Dear Sir/ Madam, Sub: Submission of Analyst I Investor Presentation Pursuant to Regulation 30(6) read with Part A of Schedule III

  2. Slide 2: Earnings Presentation – H1 / Q2-FY21

    EARNINGS PRESENTATION – H1 / Q2-FY21

  3. Slide 3: Executive Summary

    Executive Summary OVERVIEW • Ion Exchange (India) Ltd (Ion Exchange), formed in 1964, is a pioneer in water, waste water treatment & FY20: Operating environment solutions and caters to various industries, institutions, homes & communities. Income* • Headquartered in Mumbai, the company has seven man

  4. Slide 4: Company Overview

    Company Overview • Ion Exchange was originally formed as a subsidiary of Permutit, UK in 1964. It REVENUE BREAK UP FY20* became a wholly owned Indian company in 1985. The company is currently in its Consumer 56th Year of operations. Products • The company has expanded its footprints globally and pos

  5. Slide 5: H1 / Q2-FY21 Financial Highlights

    H1 / Q2- FY21 FINANCIAL HIGHLIGHTS  Q2-FY21 Performance (Consolidated):  Q2-FY21 Performance (Standalone): • Operating Income: INR 3,900 Mn • Operating Income: INR 3,753 Mn • Operating EBITDA: INR 410 Mn • Operating EBITDA: INR 422 Mn • Operating EBITDA Margins: 10.51% • Operating EBITDA Margins:

  6. Slide 6: Q2-FY21 Operational Highlights

    Q2- FY21 OPERATIONAL HIGHLIGHTS BUSINESS OPERATIONS  Improvement in performance in Q2- FY21 as compared to Q1- FY21 was due to the gradual resumption of economic activity post the progressive relaxations announced by the Central/State governments in post COVID lockdown measures.  Currently, all ou

  7. Slide 7: Q2-FY21 Standalone Income Statement (IND-AS)

    Q2-FY21 STANDALONE INCOME STATEMENT (IND-AS) INCOME STATEMENT (INR MN) Q2-FY21 Q2-FY20 Y-o-Y Q1-FY21 Q-o-Q Operating Income 3,753 3,970 (5.5)% 2,597 44.5% Expenses 3,331 3,674 (9.3)% 2,291 45.4% Operating EBITDA 422 296 42.6% 306 37.9% Operating EBITDA Margins (%) 11.24% 7.46% 378 Bps 11.78% (54) Bp

  8. Slide 8: Segmental Breakup - Quarterly Standalone

    SEGMENTAL BREAKUP- QUARTERLY STANDALONE ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) R 2,800 2,683 1,500 350 337 2,525 E 1,113 1,086 2,300 300 V 1,000 E 1,800 250 222 N 500 1,300 200 U E 800 0 150 Q2-FY20 Q2-FY21 Q2-FY20 Q2-FY21 Q2-FY20 Q2-FY21 Q2-FY20 Q2-FY21 200 300 0 163 163

  9. Slide 9: H1-FY21 Standalone Income Statement (IND-AS)

    H1-FY21 STANDALONE INCOME STATEMENT (IND-AS) INCOME STATEMENT (INR MN) H1-FY21 H1-FY20 Y-o-Y Operating Income 6,351 7,012 (9.4)% Expenses 5,622 6,497 (13.5)% Operating EBITDA 729 515 41.6% Operating EBITDA Margins (%) 11.48% 7.34% 414 Bps Depreciation 133 105 26.7% Finance Cost 58 65 (10.8)% Other I

  10. Slide 10: Segmental Breakup - Half Yearly Standalone

    SEGMENTAL BREAKUP- HALF YEARLY STANDALONE ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) R 4,800 4,420 2,500 2,275 650 611 4,144 1,940 E 2,000 550 3,800 V 422 1,500 450 E 2,800 N 1,000 350 1,800 500 250 U E 800 0 150 H1-FY20 H1-FY21 H1-FY20 H1-FY21 H1-FY20 H1-FY21 H1-FY20 H1-FY21

  11. Slide 11: Q2-FY21 Consolidated Income Statement (IND-AS)

    Q2-FY21 CONSOLIDATED INCOME STATEMENT (IND-AS) INCOME STATEMENT (INR MN) Q2-FY21 Q2-FY20 Y-o-Y Q1-FY21 Q-o-Q Operating Income 3,900 4,094 (4.7)% 2,653 47.0% Expenses 3,490 3,765 (7.3)% 2,340 49.1% Operating EBITDA 410 329 24.6% 313 31.0% Operating EBITDA Margins (%) 10.51% 8.04% 247 Bps 11.80% (129)

  12. Slide 12: Segmental Breakup - Quarterly Consolidated

    SEGMENTAL BREAKUP-QUARTERLY CONSOLIDATED ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) R 2,762 1,300 1,159 400 3,000 2,635 1,122 337 E 1,100 V 2,500 300 900 E 2,000 222 N 1,500 700 200 U 1,000 500 E 500 300 100 Q2-FY20 Q2-FY21 Q2-FY20 Q2-FY21 Q2-FY20 Q2-FY21 250 Q2-FY20 Q2-FY21

  13. Slide 13: H1-FY21 Consolidated Income Statement (IND-AS)

    H1-FY21 CONSOLIDATED INCOME STATEMENT (IND-AS) INCOME STATEMENT (INR MN) H1-FY21 H1-FY20 Y-o-Y Operating Income 6,552 7,305 (10.3)% Expenses 5,830 6,744 (13.6)% Operating EBITDA 722 561 28.7% Operating EBITDA Margins (%) 11.02% 7.68% 334 Bps Depreciation 141 113 24.8% Finance Cost 71 78 (9.0)% Other

  14. Slide 14: Segmental Breakup - Half Yearly Consolidated

    SEGMENTAL BREAKUP- HALF YEARLY CONSOLIDATED ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) R 4,633 4,336 2,800 4,500 2,354 700 E 2,300 611 1,950 V 3,500 1,800 500 422 E 2,500 N 1,300 300 U 1,500 800 E 500 300 100 H1-FY20 H1-FY21 H1-FY20 H1-FY21 H1-FY20 H1-FY21 350 307 H1-FY20 H1-

  15. Slide 15: Historical Financial Overview

    HISTORICAL FINANCIAL OVERVIEW 14

  16. Slide 16: Standalone Income Statement (IND-AS)

    STANDALONE INCOME STATEMENT (IND-AS) INCOME STATEMENT (INR MN) FY18 FY19 FY20 H1-FY21 Operating Income 9,943 11,023 14,072 6,351 Expenses 9,239 10,110 12,862 5,622 Operating EBITDA 704 913 1,210 729 Operating EBITDA Margins (%) 7.08% 8.28% 8.60% 11.48% Depreciation 119 181 221 133 Finance Cost 157 1

  17. Slide 17: Financials - Standalone

    FINANCIALS- STANDALONE REVENUES (INR MN) OPERATING EBITDA (INR MN) PAT (INR MN) REVENUE EBITDA CAGR PAT CAGR 14,072 CAGR 19% 44% 31% 1,210 913 991 11,023 9,943 704 666 478 FY18 FY19 FY20 FY18 FY19 FY20 FY18 FY19 FY20 NET DEBT/EQUITY ROE and ROCE WORKING CAPITAL DAYS FY18 FY19 FY20 66 54 17.80% 20.60

  18. Slide 18: Standalone Balance Sheet (As Per IND-AS)

    STANDALONE BALANCE SHEET (As Per IND-AS) PARTICULARS (INR MN) FY19 FY20 H1- FY21 PARTICULARS (INR MN) FY19 FY20 H1-FY21 EQUITIES & LIABILITIES ASSETS Equity Non-Current Assets (A) Equity Share Capital 147 147 147 (A) Property, Plant and Equipment 1,425 1,385 1,410 (B) Other Equity 3,597 4,668 5,169

  19. Slide 19: Consolidated Income Statement (As per IND-AS)

    CONSOLIDATED INCOME STATEMENT (As per IND-AS) INCOME STATEMENT (INR MN) FY18 FY19 FY20 H1- FY21 Operating Income 10,549 11,623 14,798 6,552 Expenses 9,779 10,557 13,452 5,830 Operating EBITDA 770 1,066 1,346 722 Operating EBITDA Margins (%) 7.30% 9.17% 9.10% 11.02% Depreciation 131 196 237 141 Finan

  20. Slide 20: Financials - Consolidated

    FINANCIALS- CONSOLIDATED REVENUES (INR MN) OPERATING EBITDA (INR MN) PAT (INR MN) REVENUE EBITDA PAT CAGR CAGR 18% CAGR 32% 940 14,798 1,346 53% 10,549 11,623 1,066 659 770 399 FY18 FY19 FY20 FY18 FY19 FY20 FY18 FY19 FY20 NET DEBT/ EQUITY ROE and ROCE WORKING CAPITAL DAYS 70 FY18 FY19 FY20 25.3% 19.

  21. Slide 21: Consolidated Balance Sheet (IND-AS)

    CONSOLIDATED BALANCE SHEET (IND-AS) PARTICULARS (INR MN) FY19 FY20 H1-FY21 PARTICULARS (INR MN) FY19 FY20 H1-FY21 EQUITIES & LIABILITIES ASSETS Equity Non-Current Assets (A) Equity Share Capital 142 142 142 (A) Property, Plant and Equipment 1,507 1,459 1,477 (B) Other Equity 2,458 3,489 3,906 (B) Ca

  22. Slide 22: Market Data

    Market Data (Bloomberg – ION IN, Reuters – IONX.BO) 1 YEAR SHARE PRICE MOVEMENT (UPTO 30th SEPTEMBER, 2020) 60% 40% 20% 0% -20% -40% Oct-19 Nov-19 Dec-19 Jan-20 Feb-20 Mar-20 Apr-20 May-20 Jun-20 Jul-20 Aug-20 Sep-20 Sensex Ion Exchange PRICE DATA (AS ON 30th SEPTEMBER, 2020) SHAREHOLDING PATTERN (A

  23. Slide 23: Disclaimer

    Disclaimer Ion Exchange (India) Limited No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all e

  24. Slide 24: Thank You

    THANK YOU

Ion Exchange (India) — H1 FY2021 Earnings Presentation on 6ix